Searched for
ZYDUS LIFESCIENCES SEMAGLUTIDE
Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...09 Apr, 2026, 02.52 PM IST- Novo Nordisk cuts Ozempic and Wegovy prices by up to 48% as GLP-1 competition intensifies in IndiaNovo Nordisk has significantly slashed prices for Ozempic and Wegovy in India, reducing them by 36% and 48% respectively, to enhance patien...31 Mar, 2026, 10.47 PM IST
- Novo Nordisk plans to cut price of Ozempic as generics hit marketNovo Nordisk is set to lower the price of its popular weight loss and diabetes drug, Ozempic. This move comes after several Indian drugmake...31 Mar, 2026, 01.01 AM IST
- Rs 12,000 crore magic pill race begins to shrink India's pot bellies. Which pharma stocks will win GLP-1 war?India's GLP-1 market is set for a massive boom. Following patent expiry, generic versions of semaglutide are launching at significantly low...24 Mar, 2026, 11.14 AM IST
- Indian drugmakers flood market with cheaper versions of Novo's Ozempic, WegovyIndian drugmakers have launched affordable generic versions of popular diabetes and weight-loss drugs. This move significantly reduces trea...23 Mar, 2026, 12.54 PM IST
- Price alone won't push weight-loss, diabetes drug semaglutide sales: DoctorsLeading drugmakers including Sun Pharmaceuticals, Dr Reddy’s Laboratories, Zydus Lifesciences, Natco Pharma, Eris Lifesciences, USV, Glenma...22 Mar, 2026, 11.19 AM IST
- Alkem Laboratories launches semaglutide in India at Rs 450 per week, eyes booming weight-loss marketAlkem Laboratories has launched a new semaglutide injection in India. This drug targets the growing diabetes and weight loss market. It is ...21 Mar, 2026, 05.07 PM IST
- Zydus, Torrent Pharma join hands to co-market Semaglutide injectionZydus Lifesciences and Torrent Pharmaceuticals have joined forces to bring a new diabetes and weight management medication to India. Zydus ...18 Mar, 2026, 05.09 PM IST
- Zydus partners with Lupin to co-market generic semaglutide in IndiaZydus Lifesciences and Lupin are joining forces. They will make a generic version of the popular weight-loss and diabetes drug semaglutide ...17 Mar, 2026, 02.23 PM IST
- Zydus, Lupin sign pact to co-market weight-loss Semaglutide injection in IndiaZydus Lifesciences and Lupin have joined forces to bring Semaglutide Injection to India. This medication helps manage type 2 diabetes and a...17 Mar, 2026, 12.22 PM IST
- Glenmark set to join peers in 'Semaglutide' pushGlenmark Pharmaceuticals is set to launch affordable versions of the popular anti-diabetes and obesity drug semaglutide. This move escalate...02 Mar, 2026, 12.21 AM IST
- Zydus plans launch of semaglutide generic in reusable pen formZydus Lifesciences is set to launch a generic version of the weight-loss injection semaglutide next month. The drug will be available under...26 Feb, 2026, 12.03 AM IST
- Eris Lifesciences eyes ‘good’ share in semaglutide generics, says COOEris Lifesciences plans to lead in generic semaglutide drugs. The patent for Novo Nordisk's drug expires in India in March 2026. Eris aims ...05 Aug, 2025, 10.50 PM IST
- Zydus Life's plans for cancer biosimilar hit a legal hurdleThe Delhi High Court has granted an interim injunction against Zydus Lifesciences, an Ahmedabad-based drug maker, following a patent infrin...21 Jul, 2025, 12.01 AM IST
- Zydus working on single pen device for adjustable Semaglutide dosesZydus Lifesciences is innovating a single-device for semaglutide. This device can deliver multiple strengths of the drug. It targets both d...23 May, 2025, 12.20 AM IST
- Weight is over! Pharma companies race to make weight-loss drug semaglutideIndian drugmakers, including Dr. Reddy's and Zydus Lifesciences, are investing heavily in manufacturing capabilities to launch generic vers...12 Apr, 2025, 06.00 AM IST
- Zydus aims to launch first new drug in US by early 2026Zydus will enter a competitive field, with an FDA decision on CymaBay's PBC drug due in August. Gilead Sciences announced its acquisition o...27 Feb, 2024, 08.34 PM IST
Load More
